Advertisement

Topics

"Grants Orphan Drug Designation Kadmon Tesevatinib Treatment EGFR" Drugs and Medication Database

13:04 EST 19th November 2017 | BioPortfolio

Here are the most relevant "Grants Orphan Drug Designation Kadmon Tesevatinib Treatment EGFR" Drugs and Medications that we have found in our database.

More Information about "Grants Orphan Drug Designation Kadmon Tesevatinib Treatment EGFR" on BioPortfolio

We have published hundreds of Grants Orphan Drug Designation Kadmon Tesevatinib Treatment EGFR news stories on BioPortfolio along with dozens of Grants Orphan Drug Designation Kadmon Tesevatinib Treatment EGFR Clinical Trials and PubMed Articles about Grants Orphan Drug Designation Kadmon Tesevatinib Treatment EGFR for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Grants Orphan Drug Designation Kadmon Tesevatinib Treatment EGFR Companies in our database. You can also find out about relevant Grants Orphan Drug Designation Kadmon Tesevatinib Treatment EGFR Drugs and Medications on this site too.

Showing "Grants Orphan Drug Designation Kadmon Tesevatinib Treatment EGFR" Drugs and Medications, all 14

CAR

Carbaglu [Orphan Europe, SARL]

These highlights do not include all the information needed to use CARBAGLU safely and effectively.  See full prescribing information for CARBAGLU.   CARBAGLU (carglumic acid) TabletsInitial U.S. Approval: 2010

DOX

Doxycycline hyclate [Corepharma LLC.]

Doxycycline Hyclate Tablets USP20 mgRx only

Doxycycline hyclate [Mutual Pharmaceutical Company, Inc.]

DOXYCYCLINE HYCLATETABLETS USP

Doxycycline hyclate [Larken Laboratories, Inc.]

DOXYCYCLINE HYCLATE TABLETS, USP

Doxycycline hyclate [IVAX Pharmaceuticals, Inc.]

DOXYCYCLINE HYCLATE TABLETS USPRx only

ERB

Erbitux [ImClone LLC]

These highlights do not include all the information needed to use ERBITUX safely and effectively. See full prescribing information for ERBITUX. ERBITUX (cetuximab)injection, for intravenous infusionInitial U.S. Approval: 2004

IRE

Iressa [AstraZeneca Pharmaceuticals LP]

IRESSA®(gefitinib)TABLETS

KEP

Kepivance [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kepivance safely and effectively. See full prescribing information for Kepivance.Kepivance® (palifermin) For injection, for intravenous useInitial U.S. Approval: 2004

KIN

Kineret [Swedish Orphan Biovitrum AB (publ)]

These highlights do not include all the information needed to use Kineret safely and effectively. See full prescribing information for Kineret. Kineret® (anakinra) For injection, for subcutaneous useInitial U.S. Approval: 2001

LEU

Leucovorin calcium [Teva Parenteral Medicines, Inc]

Leucovorin Calcium for Injection

LOV

Lovaza [Physicians Total Care, Inc.]

These highlights do not include all the information needed to use LOVAZA safely and effectively. See full prescribing information for LOVAZA. LOVAZA® (omega-3-acid ethyl esters) Capsules Initial U.S. Approval: 2004

Lovaza [GlaxoSmithKline LLC]

These highlights do not include all the information needed to use LOVAZA safely and effectively. See full prescribing information for LOVAZA. LOVAZA (omega-3-acid ethyl esters) CapsulesInitial U.S. Approval: 2004

NAS

Nasal decongestant [SUPERVALU INC.]

Equaline 44-112

VEC

Vectibix [Amgen Inc]

These highlights do not include all the information needed to use Vectibix safely and effectively. See full prescribing information for Vectibix. Vectibix (panitumumab)Injection for intravenous infusionInitial U.S. Approval: 2006



Quick Search
Advertisement